{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Faudio-recap-habp-vabp-UCpjMsg1","width":444,"version":"1.0","type":"rich","title":"HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/802f0115-ee58-4cd2-be32-05cd9db5454f/cliniciansxchange-id-audio-recap-habp-vabp-3000x3000-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b44292e7-36ae-4913-a632-f0e7ba60ae1e\" height=\"200\" width=\"100%\" title=\"HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to expert insights on key concepts in HABP/VABP and gram-negative resistance management, including epidemiology, risk factors, burden of disease, diagnostics, and optimizing treatment regimens to minimize the time to effective therapy."}